Area of research
Oncology · Surgery
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies, Hepatocellular Carcinoma Treatment and Prognosis, and Cancer Genomics and Diagnostics.
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
Combined Portal and Hepatic Vein Embolization Produces Greater Hypertrophy than Portal Vein Embolization Alone with Similar Post-Hepatectomy Outcomes and is not Impacted by Hepatic Artery Infusion Chemotherapy
Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors
Standardizing definitions and terminology of left-sided pancreatic resections through an international Delphi consensus
Advancing minimally invasive hepato-pancreato-biliary surgery: barriers to adoption and equitable access
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
Grading Pancreatic Neuroendocrine Tumors Via Endoscopic Ultrasound-guided Fine Needle Aspiration
Recurrence of Hepatocellular Carcinoma After Complete Radiologic Response to Trans-Arterial Embolization: A Retrospective Study on Patterns, Treatments, and Prognoses
Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy
Impact of enhanced recovery protocols after pancreatoduodenectomy: meta-analysis
Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes
Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial
Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial
In‐hospital opioid consumption, but not pain intensity scores, predicts 6‐month levels of pain catastrophizing following hepatic resection: A trajectory analysis
A multi‐institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer